🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sepsis is a leading cause of morbidity and mortality in intensive care unit...
Status
Completed
Location
Ghada El Adly
Start Date
2022-02-01
Trial ID
NCT05293132
Treatments Being Tested
This study aims to assess quabodepistat-based treatment regimens for RR/MDR...
Status
Recruiting
Location
Capital Medical University - Beijing Chest Hospital
Start Date
2025-10-16
Trial ID
NCT07209761
We will determine if linezolid inhibits cellular activation and production ...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00811980
Treatments Being Tested
The purpose of this study is to provide further evidence of the clinical an...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04
Trial ID
NCT00852540
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-10
Trial ID
NCT00990990
The purpose of this study is to compare clinical response to the measuremen...
Status
Completed
Location
University of South Alabama Medical Center
Start Date
2011-01
Trial ID
NCT01283581
Treatments Being Tested
This study is a single-center, randomized, controlled, open-label clinical ...
Status
Enrolling By Invitation
Location
Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis & Thoracic Tumor Research Institute
Start Date
2026-01-01
Trial ID
NCT07372781
Treatments Being Tested
Study Rationale: Previous in vitro and retrospective in vivo studies sugges...
Status
Unknown
Location
Multiple Locations
Start Date
2024-09-01
Trial ID
NCT06444802
Treatments Being Tested
This study will determine the safety, tolerability and efficacy of GSK13223...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-17
Trial ID
NCT01209078
Treatments Being Tested
Linezolid is the first approved synthetic oxazolidinone that is active agai...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2010-11
Trial ID
NCT01295801